Skip to main content

Table 1 General characteristics, atherosclerosis burden, acute phase management and medical treatments at discharge, grouped according to the depression status over a 9-month follow-up after ACS

From: High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome

  No Depression 71.3% Depression 28.7%
General characteristics   
Mean Age ± sd (years) 49.0 ± 8.8 52.2 ± 9.2
Female gender (%) 6.4 16.0
Personal history of CV disease (%) 8.1 16.0
Family history of CV disease (%) 17.7 28.0
Personal history of depression (%) 37.1 88.0 **
Familial history of depression (%) 25.8 20.0
Live alone (%) 17.7 24.0
Widow(er)/divorcee/separated (%) 45.1 48.0
Low Socio-economic level (%) 8.0 16.0
Atherosclerosis Burden   
Mean number of coronary vessels >50% stenosis 1.4+/−0.8 1.6+/−0.6
ABI < 0.9 (%) 11 7
Carotid stenosis >20% (%) 18.6 22.2
IMT > 0.7 mm (%) 63 60
ACS treatment   
Revascularisation (%) 91.9 92.0
Conventional Treatment (%) 8.1 8.0
Post ACS medications at discharge   
Beta-blocker and/or calcium antagonist 96.7% 96.0%
Cholesterol-lowering medication 93.5% 100.0%
Antiplatelet therapy or warfarin 100.0% 100.0%
ACE inhibitor or Angiotensin II receptor agonist 100.0% 96.0%
Combination of anti-ischemic/antiplatelet/Lipid-lowering drug 90.3% 96.0%
  1. *p values of tests comparing the “No depression” and “Depression” groups (Student’s t test for age, Chi square tests for proportions). * p < 0.05; ** p < 0.01.